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Antibody arrayThis study demonstrated the feasibility and beneﬁt of an antibody-based experimental approach to
identify microRNA functional targets from hundreds of predicted genes using miR-206 as an exam-
ple. Using a receptor tyrosine kinase (RTK) antibody array, we identiﬁed 7 phosphorylated RTKs that
were signiﬁcantly differentially regulated after miR-206-mimic transfection. We then focused on
MET, the most varied RTK, and bioinformatically constructed a MET-centred network using compu-
tationally predicted miR-206 targets. Within this network, we analyzed two validated targets, PAX3
and SNX2, and one candidate target, EIF4E, may account for the inhibitory effect of miR-206 on MET
phosphorylation. Luciferase and Western-blot assays indicated that EIF4E was a direct target of
miR-206. This concept may also be applicable for other microRNAs and other antibody array
platforms.
 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
MicroRNAs (miRNAs) are important regulators of gene expres-
sion in eukaryotic cells. In humans, it is estimated that miRNAs
may regulate up to 30% of the protein-coding genes. miRNAs are
known to control a broad spectrum of biological processes, and
their dysregulation may be associated with multiple diseases [1].
The identiﬁcation of functional targets is central to understanding
the molecular mechanisms by which individual miRNAs modulate
cellular functions [2].
Although some computational programs based on sequence
alignment have been widely applied to predict the targets of
miRNAs, these bioinformatic tools still yield a high percentage of
false-positives and false-negatives [3,4]. Furthermore, it is believed
that a single miRNA can regulate hundreds of target mRNAs; there-
fore, the identiﬁcation of genuine functional target genes remains a
fundamental challenge. Therefore, these obstacles underscore the
requirement for experimental data that determines functionallyimportant gene targets for elucidating the exact roles of miRNAs
in development and disease [5].
Because miRNAs can repress the expression of target genes at
the mRNA and/or protein levels, a series of experimental strategies
based on gene expression microarray or proteomic tools have been
proposed for microRNA target identiﬁcation [6]. Because most tar-
gets may be repressed by an miRNA at the protein level without
being affected at the mRNA level, proteomic methods are regarded
as the most powerful experimental strategies for revealing the full
spectrum of miRNA targets [7]. Currently, various quantitative
proteomic methodologies have been employed in the identiﬁcation
of miRNA targets, such as two-dimensional difference gel elec-
trophoresis (2D-DIGE) [8], isobaric tags for relative and absolute
quantiﬁcation (iTRAQ) [9], stable-isotope labelling by amino acids
in cell culture (SILAC) [10], and label-free quantitative proteomics
techniques [11]. These reports suggest that quantitative proteomic
approaches are valuable for experimentally identifying direct and
indirect functional miRNA targets.
Antibody-based protein microarrays have emerged as a promis-
ing high-sensitive and high-throughput tool for quantitative
proteomic research, and are superior to other mass
spectrometry-based proteomic strategies in identifying
low-abundance proteins, such as signalling molecules or kinases
[12]. Until recently, antibody-based proteomic approaches have
not been applied to miRNA target identiﬁcation. Therefore, in this
study, using the tumor-suppressor miRNA hsa-miR-206 as an
2132 Y. Cui et al. / FEBS Letters 589 (2015) 2131–2135example, we developed an antibody array-based strategy to proﬁle
miRNA-mediated receptor tyrosine kinases (RTKs) and to identify
novel miRNA-related pathway and functional targets.
2. Materials and methods
2.1. Cell culture and miR-206 transfection
The human lung adenocarcinoma cell line A549 was obtained
from the Cell Bank of the Shanghai Institute of Cell Biology,
Chinese Academy of Sciences (Shanghai, China), and cultured in
RPMI-1640 medium supplemented with 10% foetal bovine serum
(FBS) at 37 C in 5% CO2. A549 cells were seeded in 6-well plates
to reach 75% conﬂuence and transfected using hsa-miR-206 mim-
ics or negative controls (Shanghai GenePharma, China) with
Lipofectamine 2000 (Invitrogen). Cells were harvested after 48 h
of transfection.
2.2. Real-time RT-PCR analysis
Total RNA was extracted from A549 cells using TRIzol total RNA
isolation reagent (Invitrogen) according to the manufacturer’s
instructions. cDNA was synthesized from total RNA using human
miR-206RT primer. Real-time PCR was performed with a SYBR
Green PCR kit (Toyobo). U6 small nuclear RNA (snU6) was used
to normalize the expression data of miR-206.
2.3. RTK phosphorylation antibody microarray analysis
The phosphorylation levels of 71 different human receptor tyr-
osine kinases (RTKs) in cell lysates were simultaneously detected
using a RayBio Phosphorylation Antibody Array I Kit (RayBiotech,
Inc., USA) according to the manufacturer’s instructions. Brieﬂy,
A549 cells from different groups (miR-206 mimics and the
miR-negative control) were lysed and the total proteins were puri-
ﬁed using the Cell and Tissue Protein Extraction Reagent
(Kangchen, China). A BCA Protein Assay Kit (Kangchen, China)
was used to determine the concentrations. A total of 50 lg of pro-
tein extract was incubated with RTK glass slide subarrays spotted
with 71 different anti-RTK antibodies. Then, the antibody array
chips were washed and biotinylated anti-phosphotyrosine anti-
bodies were added to detect phosphorylated tyrosines on activated
RTKs. After incubation with Alexa Fluor 555-streptavidin, the sig-
nals were visualized by a ﬂuorescence scanner (GenePix 4000B).
2.4. Antibody array data analysis
Raw data collection and the background correction of microar-
rays were performed using GenePix Pro 5.1. The processed miRNA
intensity values were log-transformed and entered into the
BRB-ArrayTools software. Analyses were performed using
BRB-ArrayTools developed by Dr. Richard Simon and the
BRB-ArrayTools Development Team [13]. The chips were ﬁrst nor-
malized to the positive mean value, and then quantile normaliza-
tion was performed. The Class comparison between Groups of
Arrays tool was used to compare the signiﬁcantly differentially
expressed RTKs between A549 cells with and without miR-206
transfection. A permutation test was used, and the number of per-
mutations was 10000.
2.5. Network analysis
miR-206 targets were ﬁrst predicted by PicTar 2005, miRanda
v5 and TargetScan 5.1, and then a total of 106 genes thatoverlapped among at least two prediction sets were deﬁned as can-
didate targets for further analysis. Furthermore, this gene set was
used to search for their interaction with MET by accessing the
database STRING to create a MET-centred miR-206 target gene net-
work as described previously [14]. The links between miR-206 tar-
get genes and MET were then visualized using the Cytoscape
software.2.6. Western blot analysis
From each sample, a total of 30 lg of protein lysates was sub-
jected to 12% SDS–PAGE and electro-blotted onto PVDF mem-
branes. After blocking, the membrane was incubated overnight
with anti-EIF4E antibody (1:1000, Proteintech Group) and an
anti-b-actin antibody (1:2000, Keygentec, China) followed by
enhanced chemiluminescence detection. The Western blots were
imaged on a Gel Doc XR system (Bio-Rad).
2.7. Luciferase assay
The synthetic 30-UTR fragment of EIF4E was cloned into the
pGL3-promoter vector (Promega) at the XbaI restriction site. A
total of 1  105 cells were plated per well in 48-well plates prior
to transfection. A total of 500 ng of the pGL3-promoter constructs
and 10 ng of the Renilla luciferase plasmid pRL-TK vector
(Promega) were co-transfected with the miR-206 mimic or a
mimic control using Lipofectamine 2000 (Invitrogen) into A549
cells. After 48 h, the cells were collected for luciferase activity
assays using the Dual-Luciferase Reporter Assay System
(Promega). For each transfection, ﬁreﬂy luciferase activity was nor-
malized to that of the Renilla luciferase. All assays were performed
in triplicate from independent cell transfections.
3. Results
In this study, we developed an antibody-based quantitative
proteomics strategy to identify putative functional targets of an
example microRNA from hundreds of predicted microRNA target
genes. Our experimental schema is described in Fig. 1.
To study the modulation of miR-206 on RTKs phosphorylation
levels, we established a condition for ectopic overexpression of
miR-206 in A549 cells. Because A549 cells have a low level of
miR-206 expression, we reasoned that the magnitude of changes
in the expression and modiﬁcation of the proteins induced by ecto-
pic repression would be small; therefore the inhibitory modulation
of miR-206 was not performed in this study. We conﬁrmed that the
cellular level of miR-206 was 3-fold overexpressed following intro-
duction of the miR-206 mimic compared with non-speciﬁc con-
trols and a blank.
Using an antibody-based protein array, the expression levels of
a total of 71 phosphorylated RTKs were simultaneously screened in
A549 cells transfected with the miR-206 mimic or an miRNA
negative control. Before class comparison, the raw intensity data
of the scanned protein array images were processed in 4 steps
(background correction, log transformation, normalization relative
to positive controls, and quantile normalization) that are typically
used in oligonucleotide microarray data analysis. In this study, this
procedure yielded a high-quality normalization effect (Fig. 2A).
After data processing, miR-206-affected phosphorylated RTKs
were identiﬁed using class comparison tools in the
BRB-ArrayTools. Based on a permutation analysis of the expression
data, 7 phosphorylated RTKs were signiﬁcantly differentially
expressed in miR-206-transfected A549 cells compared with nega-
tive controls (permutation P-value <0.05), including 2 up-regulated
Fig. 2. Processing of raw intensity data of the scanned protein array images yields high-quality normalization (A). Hierarchical clustering of identical differentially expressed
RKTs between miR-206-transfected A549 cells and negative controls (B).
Fig. 1. Experimental schema of our strategy.
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Fig. 3. Visualization of the Met-centred miR-206 target genes network.
Fig. 4. Veriﬁcation of miR-206 directly targeting EIF4E using a luciferase assay. Data
are shown as the mean ± S.D. *P < 0.05 using a Student’s t test (A). Western blot
analysis showed that EIF4E expression was reduced in A549 cells when transfected
with miR-206.
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Btk, and EphA8) phosphorylated RTKs (Fig. 2B and Table S1). As
miR-206 is a potential tumor-suppressor miRNA, its downregu-
lated targets might be of more signiﬁcance in promoting cancer
progression. From the 5 downregulated targets of miR-206, we
selected the most varied RTK, HGFR (also MET) to further explore
the functional targets of miR-206.
One hundred and six common target genes predicted by three
computational algorithms were collected. We then captured the
links of these targets with MET from the context of the STRING
database, and constructed a MET-centred functional association
network (Fig. 3). Thirty-one predicted miR-206 targets entered into
this network included two validated genes, PAX3 and SNX2
[15,16]. Moreover, within this network, one predicted target gene,
EIF4E, has been reported to be a positive MET regulator, which sug-
gests that this gene might also be an miR-206 target functioning in
MET downregulation.
As indicated in Fig. 4A, the introduction of miR-206 into A549
cells with the wild-type 30-UTR EIF4E construct, signiﬁcantly
inhibited luciferase activity compared to the negative control,
and mutations in the binding sites of these two genes com-
pletely abolished the ability of miR-206 to regulate luciferase
expression. These results demonstrate that EIF4E is a direct tar-
get of miR-206. To further conﬁrm that miR-206 was indeed
responsible for the inhibition of these two novel targets, A549
cells were transfected with the miR-206 mimic or a negative
control. Western blot analysis showed while EIF4E expression
was not affected by the negative-control transfection, EIF4E
expression was dramatically reduced after transfection with
miR-206 (Fig. 4B).
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In this study, we demonstrated for the ﬁrst time the feasibility
of applying antibody array technology to identify functional
microRNA targets from a list of putative miRNA-regulated genes.
Using this strategy, a set of miR-206-repressed phosphorylated
RTKs was ﬁrst investigated, among which MET was the most
repressed RTK. We then constructed a MET-centred network, and
narrowed down a list of 106 predicted targets of miR-206 to 31
genes associated with MET expression and activation inhibition.
Filtering the list by biological context drawn from the literature
led to the selection of 3 genes (PAX3, EIF4E and SNX2), that have
supporting experimental evidence for increasing MET expression
[17–20], the suppression of these genes may at least partially
account for the role of miR-206 as a tumor suppressor. Therefore,
these 3 genes can be regarded as miR-206 targets with functional
signiﬁcance. These 3 genes include two conﬁrmed targets, PAX3
and SNX2, and one novel target, EIF4E. We further validated that
EIF4E is a direct target of miR-206 and could be repressed by
miR-206 at the protein level.
For miRNA target identiﬁcation, this antibody array-based strat-
egy is superior to mass spectrometry-based proteomic methods in
its ability to identify low-abundance miRNA targets such as RTKs
and transcription factors, which are always functionally important
targets. Despite these merits, our strategy is only limited to
RTK-biased targets. The target coverage of this array is far lower
than other unbiased quantitative proteomic strategies. Therefore,
we suggest that other protein arrays with more capacity could be
used for function-oriented miRNA target identiﬁcation in the
future.
miR-206 is downregulated in many human malignancies, and
functionally, it acts as a potential tumor suppressor [21,22].
Currently, 25 miR-206 genes in 4 species have been validated;
most of these are oncogene targets. Interestingly, MET itself is also
a direct miR-206 target [23]. Based on our ﬁndings and other evi-
dence, we propose that the repression of MET phosphorylation by
miR-206 may be due to the following three mechanisms: ﬁrst,
miR-206 directly represses MET gene expression and subsequently
decreases its phosphorylation level. Secondly, miR-206 targets the
gene PAX3, which can directly activate MET or indirectly regulate it
through MITF. Thirdly, miR-206 targets EIF4F and SNX2, thus
reducing MET expression. Therefore, our results also indicate a
more detailed regulatory mechanism for miR-206 in MET induc-
tion and activation, which helps better illustrate its role as a tumor
suppressor.
In summary, in this study, we demonstrated the utility of a pro-
tein chip- and bioinformatics-based approach for discovering func-
tional targets of miRNAs. Here, we used miR-206 and RTK antibody
arrays as a model, but this concept may also be applicable for other
miRNAs and in other types of antibody arrays.
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